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Abstract 15 
Introduction 16 
Given the high rate of falls during walking in people with idiopathic Parkinson’s disease (PD), 17 
identifying at risk individuals and developing targeted interventions to reduce falls incidence 18 
is paramount. Numerous studies have investigated gait-related risk factors for falls in PD, 19 
however findings are inconsistent across studies, and thus a synthesis of the current 20 
evidence is needed to guide clinical practice and the development of interventions to 21 
reduce falls risk. The objective of this study was to systematically review the literature 22 
regarding the association between walking biomechanics and falls in people with PD, and 23 
where possible, perform meta-analyses. 24 
Methods 25 
The study was performed in accordance with the PRISMA guidelines.  Databases were 26 
searched until January 2018 to identify articles that reported on the association between 27 
walking biomechanics and prospective or retrospective falls in people with PD. 28 
Results 29 
Twenty-six articles were included (15 prospective studies, 11 retrospective studies). Articles 30 
reported on spatiotemporal and kinematic characteristics, and muscle activation patterns. 31 
Meta-analyses revealed slower walking speed, lower cadence, shorter strides and more 32 
mediolateral head and pelvis motion in those at higher risk of future falls. Findings from 33 
prospective and retrospective articles were largely consistent. 34 
Conclusion 35 
Our findings identify spatiotemporal and kinematic characteristics of gait that are risk 36 
factors for falls in PD. Modification of these characteristics may have the potential to 37 
mediate falls risk, and future research to investigate this possibility is merited. The influence 38 
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of body and ground reaction forces, and muscle activation patterns on falls risk in PD is 39 
currently under-researched. 40 
  41 
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1. Background 42 
Falls represent a significant problem for people with idiopathic Parkinson’s Disease (PD), 43 
with ~60% of people with PD falling per year [1]. The likelihood of falls is higher than in both 44 
healthy elderly [2], and other populations prone to falling [3]. The consequences of falls are 45 
significant, including reduced quality of life [4], hospitalization [5], fractures, and 46 
subsequent to this, increased mortality [6]. While a wide range of factors are known to 47 
influence the risk of falls in people with PD [7], falls are more likely to occur during walking 48 
gait than in any other activity [8, 9]. Thus, an understanding of the role that gait mechanics 49 
plays in mediating falls risk may aid in identifying those at a higher risk of falling and with 50 
developing interventions to reduce the risk of future falls. 51 
 52 
Gait is achieved through coordinated muscle activation that results in the development of 53 
forces across joints and upon the ground, and ultimately produces movement. These muscle 54 
activation patterns (which can be measured with electromyography), joint and ground 55 
reaction forces (kinetics), and the resulting movement (kinematics), all have the potential to 56 
influence walking stability, and thus influence falls risk. Numerous approaches have been 57 
taken to quantify gait and its relation to falls in PD, and they can be broadly separated into 58 
two approaches: (i) clinical rating scales, and (ii) quantitative biomechanical measures. 59 
Clinical rating scales, such as the BESTest [10], Tinetti gait assessment [11], and Dynamic 60 
Gait Index [12], typically incorporate the assessment of multiple tasks (e.g. subjective 61 
assessment of balance during rising from a chair, standing, and walking). A summative score 62 
is then calculated based on performance across all of these components, in all tasks. As 63 
such, they are a useful clinical tool in evaluating an individual’s limitations and their risk of 64 
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falling [13], but do not identify the specific mechanics that are associated with falls. 65 
Alternatively, quantitative biomechanical measures, such as step width or cadence, 66 
represent components of walking performance that may not only provide an indication of 67 
an individual’s risk of falling, but also highlight specific modifiable gait characteristics that 68 
can be targeted with interventions to reduce the risk of future falls. With the advent of 69 
small, wireless, measurement devices such as inertial measurement units (IMUs), clinical 70 
assessment of quantitative biomechanics has now become more feasible in the clinical 71 
setting [14]. 72 
 73 
Recent consensus-based clinical practice guidelines for the management of falls risk in PD 74 
recommend basic evaluation of gait, with an emphasis on walking speed and shuffling or 75 
small-scaled gait as risk factors for falls in PD [7]. Similarly, clinical falls prediction models for 76 
PD also include the evaluation of walking speed [15]. While some prospective studies have 77 
identified slower walking speed as a risk factor for falls in PD [16-18], others found walking 78 
speed not to be a risk factor for falls in PD [19-22]. Furthermore, with the proliferation of 79 
new quantitative measures of gait in PD, with particular reference to falls, and the ability to 80 
measure these in the clinical and research environment, there is a need to synthesize these 81 
data in order to provide a clearer picture of the gait-related risk factors for falls in this 82 
population. Such an undertaking has the potential to improve the identification of “at risk” 83 
individuals, as well as inform the development of new interventions to reduce the risk of 84 
future falls in PD. 85 
 86 
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Therefore, the primary aim of this study was to systematically review the biomechanical 87 
characteristics of walking gait associated with future falls in people with PD. To ensure all 88 
possible associations between gait biomechanics and falls in PD were captured in this 89 
review, our secondary aim was to systematically review the biomechanical characteristics of 90 
walking gait associated with falls history in people with PD. 91 
 92 
2. Methods 93 
A systematic review and meta-analyses were conducted according to the PRISMA 94 
guidelines. The study protocol was pre-registered (PROSPERO 2016: CRD42016048097).  95 
 96 
2.1 Literature search and article selection 97 
2.1.1 Search strategy 98 
A search in the following databases was conducted in November 2016 and updated in 99 
January 2018: MEDLINE (PubMed), EMBASE (OVID), Scopus, CINAHL, SportsDiscus and 100 
PsychInfo. The search string was defined as follows: 101 
((((Parkinson*) OR parkinson disease[MeSH Terms])) AND ((((((((((((biomechanic*) 102 
OR kinematic*) OR kinetic*) OR electromyogra*) OR emg) OR motion analys*) OR 103 
acceler*) OR walk*) OR gait) OR locomot*) OR mobility) OR Biomechanical 104 
Phenomena[MeSH Terms])) AND ((((((((((Fall) OR Falls) OR Falling) OR Falle*) OR Trip) 105 
OR Trips) OR Tripp*) OR Slip*) OR Accident*) OR accidental falls[MeSH Terms]) 106 
In Scopus the search was performed without MeSH terms. In addition, the reference lists of 107 
all included articles were searched for additional articles that may have met the inclusion 108 
criteria. No language or publication date restrictions were imposed. 109 
 110 
2.1.2 Eligibility criteria  111 
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All original research articles investigating the biomechanical characteristics of gait 112 
associated with falls in people with idiopathic PD were considered for inclusion. Inclusion 113 
criteria were articles: (1) assessing straight-line walking, (2) measuring biomechanics 114 
(kinematics, kinetics or electromyography), (3) involving men and/or women with idiopathic 115 
PD, and (4) assessing the incidence and/or prevalence of accidental falls. Exclusion criteria 116 
were: (1) case studies, review articles, books, book chapters, conference abstracts, editorials 117 
and letters, (2) articles where idiopathic PD was not the primary disorder, (3) articles where 118 
the association between gait biomechanics and falls was not assessed. 119 
 120 
2.1.3 Data extraction and synthesis 121 
Two reviewers (MWC and MHC) independently screened the titles, abstracts and full text of 122 
articles against the inclusion/exclusion criteria. Any disagreements were resolved by a 123 
consensus discussion between the reviewers. In cases where data from the same cohort 124 
were reported in multiple articles, data from only one retrospective and one prospective 125 
analyses per factor were included (this may have been across multiple articles). Under these 126 
circumstances, inclusion was based on the largest sample size, followed by number of 127 
factors in the analysis. Where two or more articles reported the same outcome measures, a 128 
meta-analysis was performed for 1) articles that compared biomechanics between groups of 129 
prospective fallers (or repeat fallers) and non-fallers, and 2) articles that compared 130 
biomechanics between groups of retrospective fallers (or repeat fallers) and non-fallers. 131 
Furthermore, if there were three or more correlational studies examining the association 132 
between frequency of falls and the same biomechanical outcomes, these studies were also 133 
included in the meta-analysis. If we could not retrieve sufficient data from a published 134 
article, the authors were contacted and additional data were requested.  135 
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  136 
Review Manager (Version 5.3, The Nordic Cochrane Centre, Copenhagen, Denmark) was 137 
used for meta-analyses. For articles reporting between-group comparisons, effect sizes 138 
were calculated based on the standardized mean difference (SMD) in biomechanical factors. 139 
The following thresholds were used in the interpretation of the SMDs: ≤0.2 = small, >0.2 to 140 
0.5 = moderate, >0.5 to 0.7 = large, and >0.7 very large [23]. If an article included data on a 141 
biomechanical factor that was reported in different units across different articles, e.g., 142 
walking time across a fixed distance instead of walking speed, the measure represented in 143 
most articles in that specific analysis was included. Furthermore, where possible, data 144 
reported in alternative units, e.g. walking speed in km/h rather than m/s, were converted 145 
and study authors were contacted if additional data were required. Where articles reported 146 
on sub-groups (i.e. single fallers and repeat fallers), data were pooled for the purposes of 147 
meta-analysis. A random effects model was used due to the expected heterogeneity 148 
between articles stemming from different definitions of “fallers”, task conditions (e.g. 149 
footwear, walking distance etc.) and follow-up period. Between-article effect size 150 
heterogeneity was calculated with the Q-test and expressed as the I2 statistic, with 151 
threshold values of 25%, 50% and 75% considered to indicate low, moderate, and high 152 
heterogeneity, respectively [24]. Further, given the expected heterogeneity in study design, 153 
in order to evaluate the robustness of our meta-analyses, several sensitivity analyses were 154 
run independently with the exclusion of articles that adopted atypical methodological 155 
approaches in the following areas: (i) inclusion criteria (i.e. all participants were falls naïve 156 
and/or participants were not evaluated in an “on” medication state), (ii) definition of fallers 157 
(i.e. repeat fallers only), (iii) observation period (i.e. was not equal to 12 months), and (iv) 158 
data collection methods (i.e. manual observation or narrowing walkway). 159 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
9 
 
 160 
2.1.4 Quality assessment and publication bias 161 
A modified version of the checklist used by Munn et al [25] from the original checklist by 162 
Downs and Black [26] was used for assessment of methodological quality of the included 163 
articles. In our version, modifications were made to ensure criteria were relevant to 164 
retrospective and prospective articles evaluating correlations and/or between-group 165 
comparisons. We also included a modified version of item 27 from Downs and Black: “If the 166 
study had adequate power to detect any differences”. Furthermore, for item 20; “If the 167 
main outcomes were valid and reliable”, we gave two points if the answer was yes and one 168 
point if “accuracy not reported but method clearly described” (Electronic Supplementary 169 
Material S1). Articles meeting the inclusion criteria were independently assessed for 170 
methodological quality by the two reviewers (MWC and MHC). Any disagreements were 171 
resolved by a consensus discussion between the reviewers. Articles scoring 50% or more on 172 
the quality index check list were included. Visual inspection of funnel plots was used to 173 
identify publication bias. 174 
 175 
3. Results  176 
3.1 Article selection 177 
A total of 1,753 abstracts were screened against the inclusion/exclusion criteria, with 155 178 
articles proceeding to full-text screening. Twenty-seven articles proceeded to quality 179 
assessment, with one article not reaching the predefined limit of a 50% score on the quality 180 
assessment checklist (Electronic Supplementary Material S2), leaving 26 articles in this 181 
review (Figure 1; Electronic Supplementary Material S3 and S4). The primary reasons for 182 
exclusion from the review were: not assessing walking biomechanics, not assessing falls, or 183 
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not evaluating the relationship between walking biomechanics and falls. Authors of 10 184 
articles were contacted for additional data to enable inclusion within the meta-analyses. We 185 
were unable to retrieve sufficient data for 3 articles, precluding some of their data from the 186 
meta-analyses [20, 27, 28]. 187 
 188 
3.2 Study characteristics  189 
Of the included 26 articles, 15 were prospective studies, with the remaining 11 retrospective 190 
in design (Electronic Supplementary Material S3 and S4). Both retrospective and prospective 191 
findings were reported for two participant cohorts, with their data included in the relevant, 192 
separate, analyses [21, 29-31]. Three of the articles reporting on a retrospective study 193 
design evaluated correlations between gait biomechanics and number of falls [32] or 194 
presence/absence of falls [33, 34]. Given these differing definitions of falls between the 195 
articles these data could not be pooled for meta-analyses. All of the remaining articles 196 
evaluated between-group differences in walking characteristics. Twenty articles reported on 197 
walking characteristics at a “preferred” walking speed (also referred to as “comfortable” or 198 
“self-selected” pace), five articles reported on “fast” or “as fast as possible” walking speed, 199 
and five articles did not report the walking speed adopted in their study. Spatiotemporal 200 
characteristics were the most commonly reported biomechanical measures across articles, 201 
with walking speed reported in almost all articles. Measures of steps or strides (length, time 202 
and time variability) were pooled for meta-analyses as they measure the same construct. 203 
Joint and segment kinematics were reported in 5 articles and electromyography in 1 article. 204 
Kinetic measures, such as joint moments and reaction forces, were not reported in any 205 
articles. In prospective studies the occurrence of falls was monitored for between 2 and 36 206 
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months after baseline assessment, while retrospective studies assessed falls over the 207 
previous 2 to 12 months. 208 
 209 
3.3 Synthesis of results 210 
3.3.1 Spatiotemporal characteristics 211 
Meta-analysis indicated that slower walking speed was associated with increased falls risk, 212 
prospectively (Figure 2A); effect sizes were consistent across studies at preferred speed, fast 213 
speed, and in articles where walking speed was not reported. This is consistent with 214 
retrospective articles where walking speed was slower in previous fallers (SMD: -1.18; 95% 215 
CIs: -1.98 to -0.39; Electronic Supplementary Material S5). Of the studies conducted at 216 
preferred walking speed, prospective fallers had a mean (±SD) walking speed of 1.03±0.24 217 
m/s (n=486), while prospective non-fallers had a preferred walking speed of 1.14±0.21 m/s 218 
(n=626). Slower cadence (Figure 2B), and a shorter step and stride length (Figure 2C), were 219 
also observed in prospective fallers, but step width (Figure 2D) did not differ between these 220 
groups. Step and stride length were also shorter in retrospective fallers compared with non-221 
fallers (SMD: -0.83; 95% CIs: -1.39 to -0.28; Electronic Supplementary Material S5). Step and 222 
stride time, when pooled, were marginally slower in prospective fallers (Figure 2E). Step and 223 
stride time variability did not differ between prospective fallers and non-fallers (Figure 2F). 224 
 225 
**** INSERT FIGURE 2 HERE **** 226 
 227 
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In addition to the measures of gait variability reported above, one prospective article 228 
evaluated several other measures of the spatiotemporal variability of walking gait. Lord and 229 
colleagues [16] found that fallers had greater variability in stance time than non-fallers, 230 
despite there being no between-group differences in the variability of step length, step 231 
width or swing time. One retrospective article reported greater step time variability in 232 
fallers [41], while others reported no differences in stride and swing time variability [42] or 233 
walking speed variability [27]. 234 
 235 
Left-to-right symmetry of gait was reported in one prospective article [16], which showed 236 
that fallers had greater swing time asymmetry, but no differences in step time, stance time 237 
or step length asymmetry [16]. Similarly, retrospective falls research has highlighted no 238 
significant differences in left-to-right swing time symmetry between fallers and non-fallers 239 
[42]. 240 
 241 
3.3.2 Kinematics 242 
Meta-analyses of two prospective articles [22, 36], identified greater mediolateral head and 243 
pelvis motion (normalized to walking speed) in fallers versus non-fallers with large and 244 
moderate effect sizes, respectively (Figure 3). In meta-analyses of the same two articles, no 245 
differences were found in vertical head and pelvis motion normalized to walking speed or in 246 
arm swing (Figure 3) [22, 36]. 247 
 248 
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**** INSERT FIGURE 3 HERE **** 249 
 250 
In addition to head and pelvis motion, a range of other joint and body segment angles and 251 
displacements between prospective fallers and non-fallers have been reported by one 252 
research group [22, 36, 43]. Each specific variable, however, was only reported once 253 
between datasets (one dataset is reported across two articles [36, 43]), and thus these 254 
factors could not be incorporated into meta-analyses. Only knee flexion/extension range of 255 
motion was found to significantly differ between groups, with a lower range reported in 256 
fallers [36].  257 
 258 
Additional kinematic factors only reported in retrospective articles included measures of 259 
left-to-right symmetry, head and trunk accelerations and harmonic ratios. No differences in 260 
left-to-right symmetry of gait were evident between retrospective fallers and non-fallers 261 
with respect to step-to-step trunk accelerations [17], and knee flexion range of motion [27]. 262 
The magnitude of head and trunk accelerations were less in those with a history of falls [41]. 263 
Similarly, harmonic ratios of the head and trunk were lower in retrospective fallers [41], and 264 
were negatively correlated with number of falls [32], indicating less rhythmic movement of 265 
the head and trunk in fallers.  266 
 267 
3.3.3 Electromyography and Kinetics 268 
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Electromyography of three trunk muscles (thoracic erector spinae, lumbar multifidus, 269 
external oblique), measured bilaterally, were reported in one prospective article; no 270 
differences in muscle activation were reported between PD fallers and non-fallers [22]. 271 
Kinetic measures (e.g. forces) were not reported in any of the included articles. 272 
 273 
3.3.4 Sensitivity Analyses 274 
Our sensitivity analyses illustrated no change in our findings following the exclusion of 275 
studies on the basis of methodological considerations (Electronic Supplementary Material 276 
S6). In some cases (step and stride length, and step and stride time, in prospective studies), 277 
only one study remained following exclusions, and thus sensitivity analyses were not 278 
possible. 279 
 280 
3.4 Heterogeneity 281 
Low heterogeneity was observed across all analyses of prospective articles (I2 < 25%), with 282 
the exception of step and stride time variability (I2 = 43%, moderate heterogeneity), and the 283 
sub-groupings of walking speed at fast pace and where pace was not reported (I2 = 43% and 284 
45%, respectively, moderate heterogeneity). Analysis of walking speed from retrospective 285 
articles was associated with large heterogeneity (I2 = 92%), primarily resulting from the 286 
larger effect size in one article [41]. Similarly, large heterogeneity was observed in the 287 
analyses of step and stride length from retrospective articles (I2 = 53-67%). 288 
 289 
3.5 Quality assessment and publication bias 290 
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Of the included 26 articles, the median quality score was 68% (IQR: 63%-77%), with the 291 
highest article score of 79%. Items 11 and 12 (external validity), 15 (internal validity, “was an 292 
attempt made to blind those measuring the main outcomes to group membership?”) and 27 293 
(power) were those that were most frequently not reported. Visual inspection of funnel 294 
plots for each of our meta-analyses did not reveal evidence of publication bias (Figure 4). 295 
 296 
**** INSERT FIGURE 4 HERE **** 297 
 298 
4. Discussion  299 
The findings of this systematic review and meta-analysis demonstrate that slower walking 300 
speed (preferred and fast pace), lower cadence, and shorter and slower steps and strides 301 
are all associated with future falls in idiopathic PD. In addition, greater mediolateral head 302 
and pelvis motion was associated with future falls in this population. Step width did not 303 
differ between prospective PD fallers and non-fallers. A number of additional 304 
spatiotemporal and kinematic variables relating to gait variability and symmetry were either 305 
found not to differ between PD fallers and non-fallers, or were reported in only one article.  306 
 307 
Consistent with a recent review [44] and clinical guidelines [7] for the management of falls 308 
in PD, our meta-analysis highlights the increased risk of future falls with slower walking 309 
speed (at both preferred and fast pace). Similar findings were also reported in a meta-310 
analysis of healthy elderly [45], suggesting that an assessment of walking speed may be a 311 
valuable screening tool to identify falls risk in older adults, irrespective of the presence of 312 
PD. Of note, walking speed was the most frequently reported factor across articles, and our 313 
conclusions are based on a large sample (n=1,945) with low heterogeneity between articles 314 
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(I2=18%). Our meta-analyses of walking gait with retrospective falls also support an 315 
association between slower walking speed and falls in PD. These findings remained 316 
unchanged in our sensitivity analyses. Of course, it is important to recognize that numerous 317 
factors other than gait mechanics will influence the risk of future falls. That said, accurate 318 
prediction of future falls risk in the clinical setting can be achieved based on the assessment 319 
of falls history, freezing of gait and walking speed [15], underscoring the importance of 320 
walking speed in falls risk. 321 
 322 
Given that PD patients are known to walk at a slower speed than their healthy elderly 323 
counterparts [36, 46, 47], and as we have demonstrated slower walking speed in PD is 324 
associated with increased falls risk, one may consider interventions aimed at increasing 325 
walking speed. This assumes that slower walking speed plays a causative role in increasing 326 
the risk of falls in PD, however evidence of a prospective association between predictor and 327 
outcome is not sufficient to infer causation [48]. There is evidence from healthy elderly 328 
populations that faster walking speed also increases the risk of falls [49], and that gait is 329 
more stable when walking at slower speeds [50], suggesting that one may be less likely to 330 
fall when walking more slowly. Similarly, in people with PD, imposed faster walking speeds 331 
lead to a decrease in gait stability [51]. Furthermore, if ambulating at a slower walking 332 
speed, one will have a longer period of time to react to trip hazards, also potentially 333 
contributing to decreased likelihood of falls at a slower walking speed. Thus, it is possible 334 
that people with PD, particularly those with poor balance, attempt to minimize falls risk by 335 
walking slower [47], rather than slower walking speed being a risk factor for falls. A clearer 336 
understanding of the potential causative role of slower walking speed in falls may be 337 
gleaned from intervention studies aimed at increasing walking speed: if falls incidence 338 
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decreases when we increase walking speed, in combination with the prospective association 339 
between walking speed and falls, this would provide strong evidence of a causative 340 
relationship. While a number of studies have now examined the effect of treadmill training 341 
to increase walking speed [52], and there is some evidence of a short-term (2 week post-342 
intervention) effect on falls incidence [53], as yet no studies have reported on the longer 343 
term influence on falls incidence [52]. Thus, there is not yet sufficient evidence available to 344 
recommend the use of interventions to increase walking speed in order to decrease the risk 345 
of falls. Further investigation of the longer-term effects of such interventions on falls 346 
incidence is recommended. 347 
 348 
Walking speed is a product of the number of strides taken per unit of time (cadence) and 349 
the average length of each stride (stride length). Clinical guidelines for falls risk factors in PD 350 
do not currently specify whether it is a short stride length, lower cadence, or a combination 351 
of both that are associated with increased falls risk [7]. While the slowing of gait that occurs 352 
with the onset of PD is thought to occur due to a downscaling of stride length and not a 353 
decrease in cadence [54], our findings indicate that both shorter strides and a lower 354 
cadence are associated with increased risk of future falls in PD. Thus, future research trialing 355 
interventions to mediate falls risk may wish to consider the manipulation of both stride 356 
length and cadence, as both of these are compromised in PD patients at risk of future falls. 357 
 358 
By synthesizing data from two different cohorts, albeit from the same lead researcher [22, 359 
36], we have found evidence of greater mediolateral movement of the head and pelvis 360 
(when normalized to walking speed) in prospective PD fallers versus non-fallers. This may be 361 
indicative of movement of the center of mass of the body toward the outer limits of the 362 
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base of support, which would have the potential to compromise balance. Alternatively, it 363 
may be indicative of an impaired capacity for people with PD to stabilize the head during 364 
gait, thereby affecting the important role the visual and vestibular systems play in providing 365 
feedback regarding balance [55, 56]. Notably, these prospective studies found no 366 
differences in vertical head and pelvis kinematics, and did not report on anterior-posterior 367 
kinematics of the head and pelvis [22, 36]. In reviewing the retrospective literature, we 368 
identified two studies that report – in all three planes – an association between the 369 
accelerations [41] and regularity of movement [32, 41] of the head, trunk and/or pelvis and 370 
prior falls. Thus, future research regarding whether movement patterns of the upper body, 371 
particularly in the mediolateral plane, are sensitive predictors of falls risk and/or can be 372 
modified to reduce the risk of falls in PD is recommended. Furthermore, in light of the 373 
retrospective evidence [32, 41], prospective investigation of the possible role of 374 
accelerations and movement regularity in falls risk, including motion in the anterior-375 
posterior plane, would seem prudent. Given the advent of portable measurement 376 
technologies, such as inertial measurement units, it is conceivable that the use of these 377 
metrics to screen for falls risk and “retrain” movement patterns could be employed in the 378 
clinical setting in the near future. 379 
 380 
Only one article included in our review reported on differences in muscle activation patterns 381 
during walking between PD fallers and non-fallers [22]; no articles reported on the forces or 382 
moments acting on the body. While the kinematic factors (i.e. movement) reported in the 383 
included articles are typically easier to measure in a clinical setting (with the use of video or 384 
pressure mats), they do not necessarily provide a clear indication of the underlying motor 385 
patterns of the patient that drive the resulting movements. Given the differences in 386 
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movement patterns that we have identified, future research to elucidate differences in joint 387 
forces, moments and muscle activation patterns between PD fallers and non-fallers could 388 
identify specific targets for intervention to modify gait and reduce the risk of future falls. For 389 
example, the ankle plantarflexors play a significant role in driving the body forward and 390 
therefore modulating walking speed [57], their function is known to be compromised in 391 
people with PD [58] and, hence, ankle plantarflexor activation patterns and kinetics may 392 
play a role in the slower walking speeds we have identified as a risk factor for falls in this 393 
population. 394 
 395 
4.1 Limitations  396 
Our work should be considered in light of the following limitations. First, the meta-analyses 397 
relate to the bivariate associations between biomechanical factors and falls. It is possible 398 
that these relationships are influenced by a range of other factors, and thus the bivariate 399 
relationships presented in our results may not hold equally for all patients with PD. Thus, 400 
the clinician and researcher should always be cognizant of the broader range of 401 
physiological, psychological and environmental factors that are likely to influence the 402 
associations with falls that we have identified [7].  Moreover, investigation of multivariate 403 
models of falls risk (based on the characteristics associated with falls in our analyses), and 404 
subsequent evaluation of the model’s discriminative ability, would aid the clinician in 405 
delineating patients at high and low risk of falls. Second, while the data from prospective 406 
analyses provide an indication of whether biomechanical factors are risk factors for future 407 
falls, they do not provide an indication of the sensitivity and specificity of these factors in 408 
predicting future falls. Such an understanding is necessary in the utilization of these data for 409 
clinical prediction of future falls. This evidence is already available elsewhere for some 410 
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factors, such as walking speed [15, 19, 59], but is yet to be established for others, such as 411 
mediolateral head and pelvis motion. Third, other than our prospective analysis of walking 412 
speed, each of our meta-analyses were limited to between two and six studies. Thus, our 413 
power to detect publication bias was limited in these cases [60]. However, considering that 414 
the findings of our sensitivity analyses were consistent with our primary findings and that 415 
there was no visual evidence of publication bias in our funnel plots, we consider the 416 
likelihood of publication bias to be minimal. Fourth, the current study was limited to straight 417 
line walking biomechanics, yet falls frequently occur during an array of other tasks such as 418 
turning and upright standing [9]. Some studies have attempted to identify falls risk factors in 419 
some of these tasks [20, 61, 62], and this may represent an important area for future 420 
research. However, given that straight line walking is the most common task in which falls 421 
occur in people with PD [8, 9], and the ease with which this measurement can be taken in a 422 
clinical setting, it would seem prudent to focus our attention on falls-related risk factors in 423 
walking as a priority. 424 
 425 
5. Conclusions 426 
We have identified differences in some spatiotemporal and kinematic characteristics of 427 
walking gait between people with PD who fall and those who do not. From the prospective 428 
evidence, two sets of risk factors were identified: (i) spatiotemporal characteristics of slower 429 
walking speed, lower cadence, shorter step and stride length, and (ii) kinematic 430 
characteristics of greater mediolateral head and pelvis motion. This evidence may aid in 431 
identifying individuals at a higher risk of future falls, and the kinematic characteristics may 432 
represent suitable targets for intervention to reduce the risk of future falls. 433 
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Figures 603 
Figure 1. Flow chart of the article inclusion process. 604 
Figure 2. Differences in spatiotemporal characteristics of gait between prospective fallers 605 
and non-fallers. A: walking speed (n=1,945); B: cadence (n=241); C: step and stride length 606 
(n=681); D: step width (m; n=205); E: step and stride time (n=339); F: step and stride time 607 
variability (n=388). SD = standard deviation; Std. Mean Difference = Standardized mean 608 
difference; CI = Confidence interval. 609 
Figure 3. Differences in kinematic characteristics of gait between prospective fallers and 610 
non-fallers. A: normalized mediolateral head motion (n=128); B: normalized mediolateral 611 
pelvis motion (n=128); C: normalized vertical head motion (n=128); D: normalized vertical 612 
pelvis motion (n=128); E: arm swing (n=128). SD = standard deviation; Std. Mean Difference 613 
= Standardized mean difference; CI = Confidence interval. 614 
Figure 4.  Funnel plot of walking speed in prospective fallers versus non-fallers. Each point 615 
on the funnel plot represents the standardized mean difference (SMD) for an individual 616 
study (x-axis), plotted against the standard error (SE) of the standardized mean difference 617 
(y-axis). 618 
Electronic Supplementary Material 619 
ESM S1. Table. Modified Downs and Black study quality assessment tool. 620 
ESM S2. Table. Itemized scoring of risk of bias with the modified Down and Black assessment 621 
tool. 622 
ESM S3. Table. Methodological design of the included articles. 623 
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ESM S4. Table. Characteristics of participants in the included articles. 624 
ESM S5. Figure. Differences in spatiotemporal characteristics of gait between retrospective 625 
fallers and non-fallers. A: preferred walking speed (m/s; n=401); B: step and stride length 626 
(n=126). SD = standard deviation; Std. Mean Difference = Standardized mean difference; CI = 627 
Confidence interval. 628 
ESM S6. Table. Sensitivity analysis of meta-analytic findings. 629 
Highlights 
 Spatiotemporal characteristics of gait are indicative of falls risk in Parkinson’s 
disease. 
 Slower walking speed, lower cadence and shorter strides increase the risk of future 
falls. 
 Emerging evidence indicates greater head and trunk movement increases falls risk. 
 
*Highlights




Electronic Supplementary Material S1. Table. Modified Downs and Black study quality assessment 
tool. 
ITEM Yes 
Unable to 
determine No N/A Comment 
1. Is the hypothesis/aim/objective of the study 
clearly described? 
□  □   
2. Are the main outcomes to be measured 
clearly described in the Introduction or 
Methods sections? 
□  □   
3. Are the characteristics of the subjects 
included in the study clearly described? 
□  □   
5. Are the distributions of principle 
confounders in each group of subjects to be 
compared clearly described? 
□ □ 
partially 
□   
6. Are the main findings of the study clearly 
described? 
□  □   
7. Does the study provide estimates of the 
random variability in the data for the main 
outcome? 
□  □   
10. Have actual probability values been reported 
(e.g. 0.035 rather than <0.05) for the main 
outcomes except where the probability value 
is less than 0.01? 
□  □   
 
External validity 
     
11. Were the subjects asked to participate in the 
study representative to the entire population 
from which they were recruited? 
□ □ □   
12. Where those subjects who were prepared to 
participate representative of the entire 
population from which they were recruited? 
□ □ □   
 
Internal validity – Bias 
     
15. Was an attempt made to blind those 
measuring the main outcome? 
□ □ □   
16. If any of the results was based on “data 
dredging“, was this made clear? 
□ □ □   
18. Were the statistical tests used to assess the 
main outcomes appropriate? 
□ □ □   
20. Were the main outcome measures used 
accurate (valid and reliable)?  
□ □ 
Accuracy not 
reported but 
method clearly 
described 
□   
 
Internal validity – confounding (selection bias) 
     
21. Were the subjects (e.g. the two groups to be 
compared) recruited from the same 
population?  
□ □ □   
22. Were the study subjects (the two groups to 
be compared) recruited over the same 
period of time? 
□ □ □   
25. Were there adequate adjustments for 
confounding in the analyses from which the 
main findings were drawn? 
□ □ □   
 
Bias 
     
27. Did the study have sufficient power to detect 
a clinically important effect? 
□ □ □   
Every question was given 1 point for “yes” and zero points for “unable to determine” and 
“no” except for item 5 and 20, where 2 points were given for “yes” and 1 point for “partially” 
and “Accuracy not reported but method clearly described”, respectively. To be able to 
receive 2 points for item 20, the studies have to report accuracy for all gait-related 
outcomes. 
For studies that did not compare groups i.e. correlation studies, items 21 and 22 were 
excluded. For retrospective studies, items 9, 17 and 26 were excluded.  
 
 
Electronic Supplementary Material S2. Table. Itemised scoring of risk of bias with the modified Downs and Black assessment tool. 
Author, year Quality score Total 
 Reporting External validity Internal validity - Confounding Power n % 
Item 1 2 3 5 6 7 9† 10 11 12 15 16 17† 18 20 21‡ 22‡ 25 26† 27   
Maximum score /1 /1 /1 /2 /1 /1 /1 /1 /1 /1 /1 /1 /1 /1 /2 /1 /1 /1 /1 /1   
Retrospective, correlational studies (/17) 
(Christofoletti et 
al. 2016) 1 1 1 2 1 1 N/A 1 0 0 0 1 N/A 1 1 N/A N/A 1 N/A 0 12 71 
(Hubble et al. 
2016) 1 1 1 0 1 0 N/A 1 0 0 0 1 N/A 1 1 N/A N/A 0 N/A 1 9 53 
(Paker et al. 
2015) 1 1 1 1 1 1 N/A 1 0 0 0 1 N/A 1 2 N/A N/A 0 N/A 0 11 65 
Retrospective, between-group comparison (/19) 
(Kataoka et al. 
2011) 1 1 1 2 1 1 N/A 1 0 0 0 1 N/A 1 1 1 1 1 N/A 0 14 74 
(Landers et al. 
2008) 1 1 1 1 1 1 N/A 1 0 0 0 1 N/A 1 2 0 1 0 N/A 0 12 63 
(Latt et al. 2009a) 1 1 1 2 1 1 N/A 0 0 0 0 1 N/A 1 2 1 0 0 N/A 0 12 63 
(Matinolli et al. 
2009) 1 0 1 2 1 1 N/A 1 1 0 0 1 N/A 1 1 1 1 1 N/A 0 14 74 
(Plotnik et al. 
2011) 1 1 1 2 1 1 N/A 1 0 0 0 1 N/A 1 2 1 1 1 N/A 0 15 79 
(Soyuer et al. 
2017) 0 0 1 2 1 1 N/A 1 0 0 0 0 N/A 1 0 1 1 1 N/A 0 10 53 
(Toosizadeh et al. 
2015) 1 1 1 2 1 1 N/A 1 0 0 0 1 N/A 1 1 1 1 0 N/A 0 13 68 
(Weiss et al. 
2014) 1 1 1 2 1 1 N/A 1 0 0 0 1 N/A 1 1 1 1 0 N/A 0 13 68 
(Weller et al. 
1992) 0 1 1 0 1 1 N/A 1 0 0 0 0 N/A 1 0 0 1 0 N/A 0 7 37* 
†=criteria only rated in prospective studies; ‡=criteria only rated in between-group comparison studies; *=study excluded from further analysis due to total 
score <50%. 
Electronic Supplementary Material S2. Table continued. Itemised scoring of risk of bias with the modified Downs and Black assessment tool. 
Author, year Quality score Total 
 Reporting External validity Internal validity - Confounding Power n % 
Item 1 2 3 5 6 7 9† 10 11 12 15 16 17† 18 20 21‡ 22‡ 25 26† 27   
Maximum score /1 /1 /1 /2 /1 /1 /1 /1 /1 /1 /1 /1 /1 /1 /2 /1 /1 /1 /1 /1   
Prospective, between-group comparison (/22) 
(Cole et al. 2010) 1 1 1 2 1 1 0 0 0 0 0 0 1 1 1 1 1 1 0 0 13 59 
(Cole et al. 2011) 1 1 1 2 1 1 0 0 0 0 0 1 1 1 2 1 1 1 0 0 15 68 
(Cole et al. 2017) 1 1 1 2 1 1 1 0 0 0 0 1 1 1 1 1 1 0 1 1 16 73 
(Duncan et al. 
2012) 1 1 1 2 0 0 0 1 0 0 1 1 1 1 1 1 1 0 0 0 13 59 
(Duncan et al. 
2015) 1 1 1 1 1 1 0 1 0 0 0 1 1 1 1 1 1 0 0 0 13 59 
(Heinzel et al. 
2016) 1 1 0 2 1 1 0 1 0 0 0 1 1 1 0 1 1 1 0 0 13 59 
(Kataoka et al. 
2014) 1 1 1 2 1 1 1 1 0 0 0 1 1 1 0 1 1 1 0 0 15 68 
(Latt et al. 
2009b) 0 1 1 1 1 1 1 0 0 0 0 1 1 1 1 1 1 0 1 0 13 59 
(Lindholm et al. 
2015) 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 0 1 0 17 77 
(Lord et al. 2016) 1 1 1 2 1 1 0 1 0 0 0 1 1 1 2 1 1 1 1 0 17 77 
(Mak et al. 2010) 1 1 1 2 1 1 1 1 0 0 0 1 1 1 2 1 1 0 1 0 17 77 
(Matinolli et al. 
2011) 1 0 1 2 1 1 0 1 1 1 0 1 1 1 1 1 1 1 0 0 16 73 
(Paul et al. 2014) 1 1 1 2 1 1 1 1 0 0 0 1 1 1 2 1 1 0 1 0 17 77 
(Smulders et al. 
2012) 1 1 1 2 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1 0 17 77 
(Wood et al. 
2002) 1 1 1 2 1 0 1 1 1 0 0 1 1 1 1 1 1 1 1 0 17 77 
†=criteria only rated in prospective studies; ‡=criteria only rated in between-group comparison studies; *=study excluded from further analysis due to total 
score <50%. 
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Electronic Supplementary Material S3. Table. Methodological design of the included articles. 
Article Faller  Observation 
period 
Walking speed Biomechanical outcomes 
 Definition Variables Measurement tool 
Retrospective, correlational studies 
(Christofoletti et al. 2016) Two or more falls 6 months Preferred; Fast Walking speed Pressure sensitive walkway 
(Hubble et al. 2016) One or more falls 12 months Preferred Walking speed 
Axial kinematics 
(accelerations) 
Timing gates 
Accelerometers 
(Paker et al. 2015) NR 12 months Preferred Walking speed NR 
Retrospective, between-group comparison studies 
(Kataoka et al. 2011) One or more falls 6 months Preferred Walking speed 
Spatiotemporal characteristics 
Video camera (two-
dimensional) 
(Landers et al. 2008) One or more falls 12 months Preferred Walking speed NR 
(Latt et al. 2009a) One or more falls 12 months Preferred Walking speed 
Spatiotemporal characteristics 
Axial kinematics 
(accelerations) 
Accelerometers 
(Matinolli et al. 2009) One or more falls 3 months Preferred Walking speed NR 
(Plotnik et al. 2011) NR 12 months Preferred Walking speed 
Spatiotemporal characteristics 
Stopwatch 
Pressure sensitive insoles 
(Soyuer et al. 2017) NR 6 months NR Walking speed Stopwatch 
(Toosizadeh et al. 2015) One or more falls 12 months Preferred Walking speed 
Spatiotemporal characteristics 
Appendicular kinematics 
Integrated accelerometers & 
gyroscopes     
    
(Weiss et al. 2014) One or more falls 12 months Preferred Walking speed NR 
Prospective, between-group comparison studies 
(Cole et al. 2010) One or more falls 12 months Preferred Walking speed 
Spatiotemporal characteristics 
Axial & appendicular 
kinematics  
Opto-electronic motion analysis 
(three-dimensional) 
(Cole et al. 2011) One or more falls 12 months Preferred Walking speed 
Spatiotemporal characteristics 
Axial & appendicular 
kinematics 
Opto-electronic motion analysis 
(three-dimensional) 
(Cole et al. 2017) One or more falls 12 months Preferred Walking speed 
Spatiotemporal characteristics 
Axial & appendicular 
kinematics 
Axial muscle activation 
patterns 
Opto-electronic motion analysis 
(three-dimensional) 
 
 
Electromyography 
(Duncan et al. 2012) Two or more falls 6 months Preferred; fast Walking speed Pressure sensitive walkway 
(Duncan et al. 2015) One or more falls 6 months Preferred; fast Walking speed Stopwatch 
(Heinzel et al. 2016) One or more falls 2.8 ± 1 years; 
varied 
between 
participants 
Fast Walking speed NR 
(Kataoka et al. 2014) One or more falls 24 months NR Walking speed 
Spatiotemporal characteristics 
Video camera (two-
dimensional) 
(Latt et al. 2009b) One or more falls 12 months NR Walking speed 
Spatiotemporal characteristics 
Accelerometers 
(Lindholm et al. 2015) One or more falls 6 months Preferred Walking speed NR 
(Lord et al. 2016) One or more falls; 
no previous history 
of falls 
36 months Preferred Walking speed 
Spatiotemporal characteristics 
Pressure sensitive walkway 
(Mak et al. 2010) One or more falls 12 months Preferred Walking speed Pressure sensitive walkway 
(Matinolli et al. 2011) Two or more falls 24 months NR Walking speed NR 
(Paul et al. 2014) One or more falls 6 months Preferred; fast Walking speed Stopwatch 
(Smulders et al. 2012) Two or more falls 12 months Preferred Walking speed 
Spatiotemporal characteristics 
Accelerometers 
(Wood et al. 2002) One or more falls 12 months NR Walking speed 
Spatiotemporal characteristics 
NR 
NR = Not reported. 
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Electronic Supplementary Material S4. Table. Characteristics of participants in the included articles. 
Article Fallers Non-fallers 
n 
(% female) 
Age 
(mean 
± SD) 
Disease severity LEDD 
(mg/d) 
n 
(% female) 
Age 
(mean 
± SD) 
Disease severity LEDD 
(mg/d) UPDRS H&Y UPDRS H&Y 
Retrospective, correlational studies 
(Christofoletti et al. 2016) NR NR NR NR NR NR NR NR NR NR 
 Data for total sample:      
 114 (NR) 66.6 ± 
9.4 
UPDRS-
MDS III: 
34.8 ± 
10.4 
2.4 ± 0.4 810.6 ± 
640.3 
     
(Hubble et al. 2016) 23 (NR) NR NR NR NR 6 (NR) NR NR NR NR 
 Data for total sample:      
 29 (28%) 64.7 ± 
6.4 
UPDRS III: 
14.4 ± 
11.5 
1.7 ± 0.7 618.3 ± 
432.1 
     
(Paker et al. 2015) 24 (NR) NR NR NR NR 26 (NR) NR NR NR NR 
 Data for total sample:      
 50 (44%) 66.7 ± 
8.6 
NR 1.96 ± 1.2 NR      
Retrospective, between-group comparison studies 
(Kataoka et al. 2011) 15 (NR) 69.1 ± 
7.5 
UPDRS III: 
21.2 ± 
10.7 
3.0 ± 0.0 397.8 ± 
291.2 
15 (NR) 67.4 ± 
6.5 
UPDRS 
III: 17.4 
± 5.9 
3.0 ± 0.0 382.7 ± 
198.6 
 Data for total sample:     
 30 (53%) 68.3 ± 
7 
UPDRS III: 
19.3 ± 8.7 
3.0 ± 0.0 390.3 ± 
245.0 
    
(Landers et al. 2008) 25 (44%) 71.8 ± 
7.4 
UPDRS III: 
16.3 ± 5.3 
3.0 ± 0.55 NR 24 (63%) 70.1 ± 
6.9 
UPDRS 
III: 11.8 
± 5.1 
2.1 ± 
0.61 
NR 
(Latt et al. 2009a) 33 (55%) 67 ± 2 UPDRS 
Total: 42 
± 5 
3, 3-4‡ 958 ± 241 33 (55%) 63 ± 4 UPDRS 
Total: 
25 ± 4 
1, 1-1‡ 666 ± 133 
(Matinolli et al. 2009) 42 (38%) 69.4 ± 
9.3 
UPDRS 
Total: 
53.1 ± 
19.7 
2.4 ± 0.6 533.3 ± 
425.9 
77 (31%) 66.6 ± 
10.7 
UPDRS 
Total: 
39.1 ± 
15.4 
2.1 ± 0.6 337.7 ± 
266.6 
(Plotnik et al. 2011) 16 (31%) 68.6 ± 
6.7 
UPDRS 
Total: 
36.2 ± 
10.8 
2.1 ± 0.6 NR 14 (29%) 62.8 ± 
6.8 
UPDRS 
Total: 
32.7 ± 
9.7 
2.1 ± 0.6 NR 
(Soyuer et al. 2017) 22 (50%) 62.09 
± 12.5 
UPDRS 
Total: 
21.27 ± 
13.7 
2.1  ± 0.8 NR 65 (40%) 60.77 
± 12.1 
UPDRS 
Total: 
15.54 ± 
13.7 
1.9 ± 0.7 NR 
(Toosizadeh et al. 2015) NR NR NR NR NR NR NR NR NR NR 
 Data for total sample:      
 15 (47%) 71.2 ± 
6.3 
UPDRS III: 
34.8 ± 
13.9 
2.9 ± 0.9 517 ± 380      
(Weiss et al. 2014) 40 (35%) 66.5 ± 
8.21 
UPDRS-
MDS III: 
40.78 ± 
13.1 
2.9 ± 0.8 400.1 ± 
353.6 
67 (19%) 64 ± 
9.76 
UPDRS-
MDS III: 
40.15 ± 
13.35 
2.4 ± 0.5 454.6 ± 
341.8 
UPDRS = Unified Parkinson’s Disease Rating Scale; UPDRS III = Motor sub-score of the UPDRS; UPDRS-MDS III = Motor sub-score of the Movement Disorders 
Society revision of the UPDRS; H&Y = Hoehn & Yahr stage; LEDD = Levodopa equivalent daily dosage; NR = Not reported; †=median; ‡=inter-quartile range; 
¥ = absolute range. 
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Article Fallers Non-fallers 
n 
(% female) 
Age 
(mean 
± SD) 
Disease severity LEDD 
(mg/d) 
n 
(% female) 
Age 
(mean 
± SD) 
Disease severity LEDD 
(mg/d) UPDRS H&Y UPDRS H&Y 
Prospective, between-group comparison studies 
(Cole et al. 2010) 32 (38%) 66.9 ± 
11.9  
UPDRS 
Total: 
34.5 ± 
15.3  
1.8 ± 0.6 688.8 ± 
617.6 
17 (24%) 66.2 ± 
5.77 
UPDRS 
Total: 
26.6 ± 
15.3 
1.6 ± 0.6 598.8 ± 
312.6 
(Cole et al. 2011) 32 (38%) 66.9 ± 
11.9  
UPDRS 
Total: 
34.5 ± 
15.3 
1.8 ± 0.6 688.8 ± 
617.6 
17 (24%) 66.2 ± 
5.77 
UPDRS 
Total: 
26.6 ± 
15.3 
1.6 ± 0.6 598.8 ± 
312.6 
(Cole et al. 2017) 48 (40%) 69.1 ± 
8.31 
UPDRS 
Total: 
38.2 ± 
14.5 
2.1 ± 0.7 763.0 ± 
493.5 
31 (29%) 66.5 ± 
7.79 
UPDRS 
Total: 
29.4 ± 
10 
1.4 ± 0.4 489.7 ± 
337.9 
(Duncan et al. 2012) 12 (42%) 68.7 ± 
10.7 
NR 2.7 ± 0.5 NR 44 (41%) 69.6 ± 
7.96 
NR 2.3 ± 0.4 NR 
(Duncan et al. 2015) 66 (45%) 68.5 ± 
9.53 
UPDRS-
MDS III: 
35 ± 15.4 
NR NR 105 (42%) 65.51 
± 9.13 
UPDRS-
MDS III: 
29.96 ± 
10.79 
NR NR 
(Heinzel et al. 2016) 14 (36%) 64.6 ± 
7.9 
UPDRS-
MDS III: 
36.8 ± 16 
2.6 ± 0.7 NR 22 (41%) 64.2 ± 
6.7 
UPDRS-
MDS III: 
28.4 ± 
12.7 
2.3 ± 0.7 NR 
(Kataoka et al. 2014) 13 (NR) 63.8 ± 
7.3 
UPDRS III: 
22.7 ± 
10.3 
3.0 ± 0.0 405.6 ± 
225.8 
13 (NR) 66.8 ± 
6.1 
UPDRS 
III: 14.6 
± 4.6 
3.0 ± 0.0 352.1 ± 
246.0 
(Latt et al. 2009b) 51 (43%) 68.3 ± 
7.47 
NR 2.5 ± 0.7 NR 62 (44%) 64.4 ± 
10.6 
NR 1.6 ± 0.7 NR 
(Lindholm et al. 2015) 45 (NR) NR NR NR NR 96 (NR) NR NR NR NR 
 Data for total sample:      
 141 (46%) 68 ± 
9.7 
UPDRS III: 
13†, 8-18‡ 
2†, 2-3‡ 400†, 286-
600‡ 
     
(Lord et al. 2016) 47 (32%) 68.8 ± 
10.7 
UPDRS-
MDS III: 
24.6 ± 9 
2.0 ± 0.7 164.3 ± 
151.2 
30 (17%) 68 ± 
8.2 
UPDRS-
MDS III: 
23.6 ± 
11.7 
1.8 ± 0.6 164.1 ± 
129.5 
(Mak et al. 2010) 25 (48%) 62.99 
± 7.8 
UPDRS III: 
25.93 ± 
9.77 
2.8 ± 0.6 590.5 ± 
415.9 
47 (47%) 63.7 ± 
8.4 
UPDRS 
III: 21.3 
± 9.4 
2.6 ± 0.4 379.9 ± 
310.9 
(Matinolli et al. 2011) 59 (36%) 68.9 ± 
10.4 
UPDRS 
Total: 
51.6 ± 21 
2.4 ± 0.7 526.3 ± 
406.5 
66 (32%) 67.1 ± 
10.1 
UPDRS 
Total: 
39.4 ± 
14.7 
2.1 ± 0.6 309.9 ± 
235.9 
(Paul et al. 2014) 120 (48%) 68.7 ± 
9.6 
UPDRS III: 
25.9 ± 
11.7 
2.6 ± 0.6 NR 85 (35%) 66.8 ± 
8.8 
UPDRS 
III: 23.4 
± 10.9 
2.4 ± 0.6 NR 
(Smulders et al. 2012) 91 (37%) 66.3 ± 
7.5 
UPDRS III: 
36.7 ± 9.4 
2.0 ± 0.3 NR 171 (35%) 64.6 ± 
8.1 
UPDRS 
III: 32.7 
± 9.1 
2.0 ± 0.2 NR 
(Wood et al. 2002) 69 (46%) 75†, 
54-92¥ 
UPDRS 
Total: 37†, 
8-64¥ 
2.0†, 1-4¥ 400†, 0-
1250¥ 
32 (59%) 75†, 
60-92¥ 
UPDRS 
Total: 
28†, 9-
44¥ 
1.5†, 1-
3¥ 
375†, 0-
800¥ 
UPDRS = Unified Parkinson’s Disease Rating Scale; UPDRS III = Motor sub-score of the UPDRS; UPDRS-MDS III = Motor sub-score of the Movement Disorders 
Society revision of the UPDRS; H&Y = Hoehn & Yahr stage; LEDD = Levodopa equivalent daily dosage; NR = Not reported; †=median; ‡=inter-quartile range; 
¥ = absolute range. 
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Electronic Supplementary Material S6. Table. Sensitivity analysis of meta-analytic findings. 
 All studies Atypical inclusion criteria Atypical definition of fallers Atypical observation period Atypical data collection methods Findings with 
exclusion of studies Factor Studies 
(n) 
Participants 
(n) 
SMD Studies 
(n) 
Participants 
(n) 
SMD Studies 
(n) 
Participants 
(n) 
SMD Studies 
(n) 
Participants 
(n) 
SMD Studies 
(n) 
Participants 
(n) 
SMD 
Prospective studies 
Walking 
speed 
14 1945 -0.48 
[-0.59, -0.37] 
8 1216 -0.52 
[-0.66, -0.37] 
11 1446 -0.54 
[-0.66, -0.43] 
6 676 -0.37 
[-0.53, -0.21] 
13 1919 -0.46 
[-0.56, -0.37] 
No changes 
Cadence 3 241 -0.28 
[-0.54, -0.02] 
No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No changes 
Step width 3 205 0.05 
[-0.34, 0.23] 
2 128 -0.11 
[-0.47, 0.26] 
No 
studies 
removed 
N/A N/A 2 128 -0.11 
[-0.47, 0.26] 
No 
studies 
removed 
N/A N/A No changes 
Step / stride 
length 
6 681 -0.35 
[-0.51, -0.20] 
3 205 -0.29 
[-0.55, -0.03] 
5 419 -0.36 
[-0.56, -0.16] 
5 604 -0.33 
[-0.50, -0.16] 
5 580 -0.35 
[-0.51, -0.18] 
No changes 
Step/stride 
time 
2 339 0.24 
[0.01, 0.46] 
0 N/A N/A 1 N/A N/A 1 N/A N/A No 
studies 
removed 
N/A N/A No changes; in three 
analyses insufficient 
studies retained to 
perform meta-analyses 
Step/stride 
time 
variability 
3 388 0.21 
[-0.11, 0.52] 
1 N/A N/A 2 126 0.36 
[-0.08, 0.81] 
2 311 0.06 
[-0.17, 0.29] 
No 
studies 
removed 
N/A N/A No changes; in one 
analysis insufficient 
studies retained to 
perform meta-analyses 
Normalized 
mediolateral 
head motion 
2 128 0.53 
[0.12, 0.95] 
No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No changes 
Normalized 
mediolateral 
pelvis 
motion 
2 128 0.45 
[0.09, 0.81] 
No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No changes 
Normalized 
vertical head 
motion 
2 128 0.26 
[-0.10, 0.62] 
No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No changes 
Normalized 
vertical 
pelvis 
motion 
2 128 0.20 
[-0.16, 0.56] 
No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No changes 
Arm swing 2 128 -0.07 
[-0.44, 0.30] 
No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No 
studies 
removed 
N/A N/A No changes 
Retrospective studies 
Walking 
speed 
6 401 -1.18 
[-1.98, -0.39] 
4 264 -1.38 
[-2.72, -0.04] 
5 371 -1.30 
[-2.23, -0.37] 
4 252 -1.46 
[-2.78, -0.14] 
5 371 -1.26 
[-2.19, -0.33] 
No changes 
Step / stride 
length 
3 126 -0.83 
[-1.39, -0.28] 
2 96 -0.97 
[-1.70, -0.23] 
2 96 -0.94 
[-1.72, -0.16] 
2 96 -0.97 
[-1.70, -0.23] 
2 96 -0.97 
[-1.70, -0.23] 
No changes 
 
